Bioo Scientific has recently introduced the RNA-Lancer II, a delivery agent for in vivo RNAi research.
According to the company, the product uses a set of neutral hydrophobic molecules to encapsulate and deliver RNAi agents into tissues for both target validation and therapeutic development applications.
Qiagen has launched miScript miRNA mimics and miScript miRNA inhibitors.
According to the company, the products come ready-to-transfect for use in gene regulation and cellular pathway analysis.
The miRNA mimics are synthetic RNA oligonucleotides that function like mature endogenous miRNA molecules when transfected in to mammalian cells and can be used to artificially up-regulate the level of any miRNA in a cell.
The inhibitors are synthetic chemically modified RNA oligonucleotides that inhibit endogenously expressed miRNAs. miRNA Inhibitors effectively lower the endogenous levels of miRNA in cells enabling loss-of-function studies.